Pertussis Vaccine-Global Market Status and Trend Report 2013-2023
Report Summary
Pertussis Vaccine-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pertussis Vaccine industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Pertussis Vaccine 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Pertussis Vaccine worldwide, with company and product introduction, position in the Pertussis Vaccine market
Market status and development trend of Pertussis Vaccine by types and applications
Cost and profit status of Pertussis Vaccine, and marketing status
Market growth drivers and challenges
The report segments the global Pertussis Vaccine market as:
Global Pertussis Vaccine Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Pertussis Vaccine Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Whole-cell Vaccines
Acellular Vaccines
Global Pertussis Vaccine Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Children Application
Adults Application
Global Pertussis Vaccine Market: Manufacturers Segment Analysis (Company and Product introduction, Pertussis Vaccine Sales Volume, Revenue, Price and Gross Margin):
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma Corporation
Astellas Pharma
Minhai Biotechnology
Wuhan Institute of Biological Products
Changchun Changsheng Life Sciences
Beijing Tiantan Biological Products
Chengdu Institute of Biological Products
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Pertussis Vaccine-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pertussis Vaccine industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Pertussis Vaccine 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Pertussis Vaccine worldwide, with company and product introduction, position in the Pertussis Vaccine market
Market status and development trend of Pertussis Vaccine by types and applications
Cost and profit status of Pertussis Vaccine, and marketing status
Market growth drivers and challenges
The report segments the global Pertussis Vaccine market as:
Global Pertussis Vaccine Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Pertussis Vaccine Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Whole-cell Vaccines
Acellular Vaccines
Global Pertussis Vaccine Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Children Application
Adults Application
Global Pertussis Vaccine Market: Manufacturers Segment Analysis (Company and Product introduction, Pertussis Vaccine Sales Volume, Revenue, Price and Gross Margin):
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma Corporation
Astellas Pharma
Minhai Biotechnology
Wuhan Institute of Biological Products
Changchun Changsheng Life Sciences
Beijing Tiantan Biological Products
Chengdu Institute of Biological Products
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PERTUSSIS VACCINE
1.1 Definition of Pertussis Vaccine in This Report
1.2 Commercial Types of Pertussis Vaccine
1.2.1 Whole-cell Vaccines
1.2.2 Acellular Vaccines
1.3 Downstream Application of Pertussis Vaccine
1.3.1 Children Application
1.3.2 Adults Application
1.4 Development History of Pertussis Vaccine
1.5 Market Status and Trend of Pertussis Vaccine 2013-2023
1.5.1 Global Pertussis Vaccine Market Status and Trend 2013-2023
1.5.2 Regional Pertussis Vaccine Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Pertussis Vaccine 2013-2017
2.2 Sales Market of Pertussis Vaccine by Regions
2.2.1 Sales Volume of Pertussis Vaccine by Regions
2.2.2 Sales Value of Pertussis Vaccine by Regions
2.3 Production Market of Pertussis Vaccine by Regions
2.4 Global Market Forecast of Pertussis Vaccine 2018-2023
2.4.1 Global Market Forecast of Pertussis Vaccine 2018-2023
2.4.2 Market Forecast of Pertussis Vaccine by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Pertussis Vaccine by Types
3.2 Sales Value of Pertussis Vaccine by Types
3.3 Market Forecast of Pertussis Vaccine by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Pertussis Vaccine by Downstream Industry
4.2 Global Market Forecast of Pertussis Vaccine by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Pertussis Vaccine Market Status by Countries
5.1.1 North America Pertussis Vaccine Sales by Countries (2013-2017)
5.1.2 North America Pertussis Vaccine Revenue by Countries (2013-2017)
5.1.3 United States Pertussis Vaccine Market Status (2013-2017)
5.1.4 Canada Pertussis Vaccine Market Status (2013-2017)
5.1.5 Mexico Pertussis Vaccine Market Status (2013-2017)
5.2 North America Pertussis Vaccine Market Status by Manufacturers
5.3 North America Pertussis Vaccine Market Status by Type (2013-2017)
5.3.1 North America Pertussis Vaccine Sales by Type (2013-2017)
5.3.2 North America Pertussis Vaccine Revenue by Type (2013-2017)
5.4 North America Pertussis Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Pertussis Vaccine Market Status by Countries
6.1.1 Europe Pertussis Vaccine Sales by Countries (2013-2017)
6.1.2 Europe Pertussis Vaccine Revenue by Countries (2013-2017)
6.1.3 Germany Pertussis Vaccine Market Status (2013-2017)
6.1.4 UK Pertussis Vaccine Market Status (2013-2017)
6.1.5 France Pertussis Vaccine Market Status (2013-2017)
6.1.6 Italy Pertussis Vaccine Market Status (2013-2017)
6.1.7 Russia Pertussis Vaccine Market Status (2013-2017)
6.1.8 Spain Pertussis Vaccine Market Status (2013-2017)
6.1.9 Benelux Pertussis Vaccine Market Status (2013-2017)
6.2 Europe Pertussis Vaccine Market Status by Manufacturers
6.3 Europe Pertussis Vaccine Market Status by Type (2013-2017)
6.3.1 Europe Pertussis Vaccine Sales by Type (2013-2017)
6.3.2 Europe Pertussis Vaccine Revenue by Type (2013-2017)
6.4 Europe Pertussis Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Pertussis Vaccine Market Status by Countries
7.1.1 Asia Pacific Pertussis Vaccine Sales by Countries (2013-2017)
7.1.2 Asia Pacific Pertussis Vaccine Revenue by Countries (2013-2017)
7.1.3 China Pertussis Vaccine Market Status (2013-2017)
7.1.4 Japan Pertussis Vaccine Market Status (2013-2017)
7.1.5 India Pertussis Vaccine Market Status (2013-2017)
7.1.6 Southeast Asia Pertussis Vaccine Market Status (2013-2017)
7.1.7 Australia Pertussis Vaccine Market Status (2013-2017)
7.2 Asia Pacific Pertussis Vaccine Market Status by Manufacturers
7.3 Asia Pacific Pertussis Vaccine Market Status by Type (2013-2017)
7.3.1 Asia Pacific Pertussis Vaccine Sales by Type (2013-2017)
7.3.2 Asia Pacific Pertussis Vaccine Revenue by Type (2013-2017)
7.4 Asia Pacific Pertussis Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Pertussis Vaccine Market Status by Countries
8.1.1 Latin America Pertussis Vaccine Sales by Countries (2013-2017)
8.1.2 Latin America Pertussis Vaccine Revenue by Countries (2013-2017)
8.1.3 Brazil Pertussis Vaccine Market Status (2013-2017)
8.1.4 Argentina Pertussis Vaccine Market Status (2013-2017)
8.1.5 Colombia Pertussis Vaccine Market Status (2013-2017)
8.2 Latin America Pertussis Vaccine Market Status by Manufacturers
8.3 Latin America Pertussis Vaccine Market Status by Type (2013-2017)
8.3.1 Latin America Pertussis Vaccine Sales by Type (2013-2017)
8.3.2 Latin America Pertussis Vaccine Revenue by Type (2013-2017)
8.4 Latin America Pertussis Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Pertussis Vaccine Market Status by Countries
9.1.1 Middle East and Africa Pertussis Vaccine Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Pertussis Vaccine Revenue by Countries (2013-2017)
9.1.3 Middle East Pertussis Vaccine Market Status (2013-2017)
9.1.4 Africa Pertussis Vaccine Market Status (2013-2017)
9.2 Middle East and Africa Pertussis Vaccine Market Status by Manufacturers
9.3 Middle East and Africa Pertussis Vaccine Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Pertussis Vaccine Sales by Type (2013-2017)
9.3.2 Middle East and Africa Pertussis Vaccine Revenue by Type (2013-2017)
9.4 Middle East and Africa Pertussis Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF PERTUSSIS VACCINE
10.1 Global Economy Situation and Trend Overview
10.2 Pertussis Vaccine Downstream Industry Situation and Trend Overview
CHAPTER 11 PERTUSSIS VACCINE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Pertussis Vaccine by Major Manufacturers
11.2 Production Value of Pertussis Vaccine by Major Manufacturers
11.3 Basic Information of Pertussis Vaccine by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Pertussis Vaccine Major Manufacturer
11.3.2 Employees and Revenue Level of Pertussis Vaccine Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 PERTUSSIS VACCINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Sanofi Pasteur
12.1.1 Company profile
12.1.2 Representative Pertussis Vaccine Product
12.1.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Sanofi Pasteur
12.2 GSK
12.2.1 Company profile
12.2.2 Representative Pertussis Vaccine Product
12.2.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of GSK
12.3 Mitsubishi Tanabe Pharma Corporation
12.3.1 Company profile
12.3.2 Representative Pertussis Vaccine Product
12.3.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Mitsubishi Tanabe Pharma Corporation
12.4 Astellas Pharma
12.4.1 Company profile
12.4.2 Representative Pertussis Vaccine Product
12.4.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Astellas Pharma
12.5 Minhai Biotechnology
12.5.1 Company profile
12.5.2 Representative Pertussis Vaccine Product
12.5.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Minhai Biotechnology
12.6 Wuhan Institute of Biological Products
12.6.1 Company profile
12.6.2 Representative Pertussis Vaccine Product
12.6.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Wuhan Institute of Biological Products
12.7 Changchun Changsheng Life Sciences
12.7.1 Company profile
12.7.2 Representative Pertussis Vaccine Product
12.7.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Changchun Changsheng Life Sciences
12.8 Beijing Tiantan Biological Products
12.8.1 Company profile
12.8.2 Representative Pertussis Vaccine Product
12.8.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Beijing Tiantan Biological Products
12.9 Chengdu Institute of Biological Products
12.9.1 Company profile
12.9.2 Representative Pertussis Vaccine Product
12.9.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Chengdu Institute of Biological Products
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PERTUSSIS VACCINE
13.1 Industry Chain of Pertussis Vaccine
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF PERTUSSIS VACCINE
14.1 Cost Structure Analysis of Pertussis Vaccine
14.2 Raw Materials Cost Analysis of Pertussis Vaccine
14.3 Labor Cost Analysis of Pertussis Vaccine
14.4 Manufacturing Expenses Analysis of Pertussis Vaccine
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Pertussis Vaccine in This Report
1.2 Commercial Types of Pertussis Vaccine
1.2.1 Whole-cell Vaccines
1.2.2 Acellular Vaccines
1.3 Downstream Application of Pertussis Vaccine
1.3.1 Children Application
1.3.2 Adults Application
1.4 Development History of Pertussis Vaccine
1.5 Market Status and Trend of Pertussis Vaccine 2013-2023
1.5.1 Global Pertussis Vaccine Market Status and Trend 2013-2023
1.5.2 Regional Pertussis Vaccine Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Pertussis Vaccine 2013-2017
2.2 Sales Market of Pertussis Vaccine by Regions
2.2.1 Sales Volume of Pertussis Vaccine by Regions
2.2.2 Sales Value of Pertussis Vaccine by Regions
2.3 Production Market of Pertussis Vaccine by Regions
2.4 Global Market Forecast of Pertussis Vaccine 2018-2023
2.4.1 Global Market Forecast of Pertussis Vaccine 2018-2023
2.4.2 Market Forecast of Pertussis Vaccine by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Pertussis Vaccine by Types
3.2 Sales Value of Pertussis Vaccine by Types
3.3 Market Forecast of Pertussis Vaccine by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Pertussis Vaccine by Downstream Industry
4.2 Global Market Forecast of Pertussis Vaccine by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Pertussis Vaccine Market Status by Countries
5.1.1 North America Pertussis Vaccine Sales by Countries (2013-2017)
5.1.2 North America Pertussis Vaccine Revenue by Countries (2013-2017)
5.1.3 United States Pertussis Vaccine Market Status (2013-2017)
5.1.4 Canada Pertussis Vaccine Market Status (2013-2017)
5.1.5 Mexico Pertussis Vaccine Market Status (2013-2017)
5.2 North America Pertussis Vaccine Market Status by Manufacturers
5.3 North America Pertussis Vaccine Market Status by Type (2013-2017)
5.3.1 North America Pertussis Vaccine Sales by Type (2013-2017)
5.3.2 North America Pertussis Vaccine Revenue by Type (2013-2017)
5.4 North America Pertussis Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Pertussis Vaccine Market Status by Countries
6.1.1 Europe Pertussis Vaccine Sales by Countries (2013-2017)
6.1.2 Europe Pertussis Vaccine Revenue by Countries (2013-2017)
6.1.3 Germany Pertussis Vaccine Market Status (2013-2017)
6.1.4 UK Pertussis Vaccine Market Status (2013-2017)
6.1.5 France Pertussis Vaccine Market Status (2013-2017)
6.1.6 Italy Pertussis Vaccine Market Status (2013-2017)
6.1.7 Russia Pertussis Vaccine Market Status (2013-2017)
6.1.8 Spain Pertussis Vaccine Market Status (2013-2017)
6.1.9 Benelux Pertussis Vaccine Market Status (2013-2017)
6.2 Europe Pertussis Vaccine Market Status by Manufacturers
6.3 Europe Pertussis Vaccine Market Status by Type (2013-2017)
6.3.1 Europe Pertussis Vaccine Sales by Type (2013-2017)
6.3.2 Europe Pertussis Vaccine Revenue by Type (2013-2017)
6.4 Europe Pertussis Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Pertussis Vaccine Market Status by Countries
7.1.1 Asia Pacific Pertussis Vaccine Sales by Countries (2013-2017)
7.1.2 Asia Pacific Pertussis Vaccine Revenue by Countries (2013-2017)
7.1.3 China Pertussis Vaccine Market Status (2013-2017)
7.1.4 Japan Pertussis Vaccine Market Status (2013-2017)
7.1.5 India Pertussis Vaccine Market Status (2013-2017)
7.1.6 Southeast Asia Pertussis Vaccine Market Status (2013-2017)
7.1.7 Australia Pertussis Vaccine Market Status (2013-2017)
7.2 Asia Pacific Pertussis Vaccine Market Status by Manufacturers
7.3 Asia Pacific Pertussis Vaccine Market Status by Type (2013-2017)
7.3.1 Asia Pacific Pertussis Vaccine Sales by Type (2013-2017)
7.3.2 Asia Pacific Pertussis Vaccine Revenue by Type (2013-2017)
7.4 Asia Pacific Pertussis Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Pertussis Vaccine Market Status by Countries
8.1.1 Latin America Pertussis Vaccine Sales by Countries (2013-2017)
8.1.2 Latin America Pertussis Vaccine Revenue by Countries (2013-2017)
8.1.3 Brazil Pertussis Vaccine Market Status (2013-2017)
8.1.4 Argentina Pertussis Vaccine Market Status (2013-2017)
8.1.5 Colombia Pertussis Vaccine Market Status (2013-2017)
8.2 Latin America Pertussis Vaccine Market Status by Manufacturers
8.3 Latin America Pertussis Vaccine Market Status by Type (2013-2017)
8.3.1 Latin America Pertussis Vaccine Sales by Type (2013-2017)
8.3.2 Latin America Pertussis Vaccine Revenue by Type (2013-2017)
8.4 Latin America Pertussis Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Pertussis Vaccine Market Status by Countries
9.1.1 Middle East and Africa Pertussis Vaccine Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Pertussis Vaccine Revenue by Countries (2013-2017)
9.1.3 Middle East Pertussis Vaccine Market Status (2013-2017)
9.1.4 Africa Pertussis Vaccine Market Status (2013-2017)
9.2 Middle East and Africa Pertussis Vaccine Market Status by Manufacturers
9.3 Middle East and Africa Pertussis Vaccine Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Pertussis Vaccine Sales by Type (2013-2017)
9.3.2 Middle East and Africa Pertussis Vaccine Revenue by Type (2013-2017)
9.4 Middle East and Africa Pertussis Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF PERTUSSIS VACCINE
10.1 Global Economy Situation and Trend Overview
10.2 Pertussis Vaccine Downstream Industry Situation and Trend Overview
CHAPTER 11 PERTUSSIS VACCINE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Pertussis Vaccine by Major Manufacturers
11.2 Production Value of Pertussis Vaccine by Major Manufacturers
11.3 Basic Information of Pertussis Vaccine by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Pertussis Vaccine Major Manufacturer
11.3.2 Employees and Revenue Level of Pertussis Vaccine Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 PERTUSSIS VACCINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Sanofi Pasteur
12.1.1 Company profile
12.1.2 Representative Pertussis Vaccine Product
12.1.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Sanofi Pasteur
12.2 GSK
12.2.1 Company profile
12.2.2 Representative Pertussis Vaccine Product
12.2.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of GSK
12.3 Mitsubishi Tanabe Pharma Corporation
12.3.1 Company profile
12.3.2 Representative Pertussis Vaccine Product
12.3.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Mitsubishi Tanabe Pharma Corporation
12.4 Astellas Pharma
12.4.1 Company profile
12.4.2 Representative Pertussis Vaccine Product
12.4.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Astellas Pharma
12.5 Minhai Biotechnology
12.5.1 Company profile
12.5.2 Representative Pertussis Vaccine Product
12.5.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Minhai Biotechnology
12.6 Wuhan Institute of Biological Products
12.6.1 Company profile
12.6.2 Representative Pertussis Vaccine Product
12.6.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Wuhan Institute of Biological Products
12.7 Changchun Changsheng Life Sciences
12.7.1 Company profile
12.7.2 Representative Pertussis Vaccine Product
12.7.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Changchun Changsheng Life Sciences
12.8 Beijing Tiantan Biological Products
12.8.1 Company profile
12.8.2 Representative Pertussis Vaccine Product
12.8.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Beijing Tiantan Biological Products
12.9 Chengdu Institute of Biological Products
12.9.1 Company profile
12.9.2 Representative Pertussis Vaccine Product
12.9.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Chengdu Institute of Biological Products
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PERTUSSIS VACCINE
13.1 Industry Chain of Pertussis Vaccine
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF PERTUSSIS VACCINE
14.1 Cost Structure Analysis of Pertussis Vaccine
14.2 Raw Materials Cost Analysis of Pertussis Vaccine
14.3 Labor Cost Analysis of Pertussis Vaccine
14.4 Manufacturing Expenses Analysis of Pertussis Vaccine
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
